Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
800 studies found for:    "Heparin"
Show Display Options
Rank Status Study
1 Unknown  DEDICA (Dose of HEparin During Coronary Angioplasty) Trial
Conditions: Stable Angina;   Angina, Unstable;   Non-ST Elevation (NSTEMI) Myocardial Infarction
Interventions: Drug: Low-dose heparin;   Drug: Standard dose heparin
2 Recruiting A Comparison of Dilute Versus Concentrated Heparin for CRRT Anticoagulation
Conditions: Acute Kidney Injury;   Acute Renal Failure;   Heart Failure
Interventions: Drug: Dilute unfractionated heparin;   Drug: Standard concentration unfractionated heparin
3 Completed Comparative Study of Two Brands of Heparin Already on the Market
Condition: Coronary Artery Bypass Grafting
Intervention: Drug: Heparin Leo and Hepalean
4 Completed Pregnancy Outcomes in Women With Recurrent Miscarriage Treated With Low Dose Aspirin and Unfractionated Heparin
Condition: Recurrent Miscarriage
Intervention: Drug: Heparin
5 Completed Effect of Heparin on Femoral Arterial Sheaths Thrombosis During Diagnostic Coronary Angiography
Condition: Diagnostic Coronary Angiography
Intervention: Drug: Heparin
6 Completed Multi-center Study to Investigate the Effects of Citrasate® on Heparin N Requirements During Hemodialysis Treatment
Condition: Renal Dialysis
Intervention: Drug: Heparin N reduction
7 Completed Effects of Heparin on Arteriovenous Fistula Patency
Condition: Arteriovenous Fistula
Intervention: Drug: Heparin
8 Terminated Balloon Aortic Valvuloplasty Performed Without Heparin to Decrease Vascular and Bleeding Complications of the Procedure
Condition: Aortic Stenosis, Non-rheumatic
Interventions: Drug: Heparin;   Drug: NaCl
9 Not yet recruiting Efficacy and Safety of Unfractionated Heparin on Severe Sepsis With Suspected Disseminated Intravascular Coagulation
Conditions: Sepsis;   Disseminated Intravascular Coagulation
Interventions: Drug: Heparin Sodium;   Drug: Saline
10 Completed HEROIC (Heparin Requirement in Counterpulsation)
Condition: Cardiogenic Shock
Interventions: Drug: Heparin;   Other: Without Heparin
11 Completed Randomized Comparison of Continuous and Intermittent Heparin Infusion During Catheter Ablation of Atrial Fibrillation
Condition: Coagulation; Intravascular
Interventions: Drug: Continuous heparin infusion;   Drug: Intermittent heparin infusion
12 Recruiting High (100IU/Kg) Versus Standard (50IU/Kg) Heparin Dose for Prevention of Forearm Artery Occlusion
Condition: Coronary Angiography
Interventions: Drug: High dose of Unfractionated Heparin;   Drug: Standard dose of Unfractionated heparin
13 Recruiting Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin
Conditions: Aneurysmal Subarachnoid Hemorrhage;   Neurobehavioral Manifestations;   Vasospasm, Intracranial;   Intracranial Aneurysm;   Heparin-induced Thrombocytopenia Type II
Intervention: Drug: Continuous Low-Dose Intravenous Unfractionated Heparin Infusion (14 days)
14 Withdrawn The Effect of Heparin on Inhalation Injury
Condition: Heparin
Interventions: Drug: standard care;   Drug: Heparin
15 Recruiting Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill Patients
Condition: Venous Thromboembolism
Interventions: Drug: intravenous continuous infusion of heparin (IV UFH);   Drug: Subcutaneous Heparin
16 Completed The Effect of Heparin in Treatment IVF-ET Failure
Conditions: Pregnancy;   Thrombophilia
Intervention: Drug: heparin
17 Completed Heparin Dose for Radial Angiography
Condition: Coronary Angiograph
Intervention: Drug: unfractionated heparin
18 Completed Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI
Condition: Coronary Artery Disease
Intervention: Drug: unfractionated heparin
19 Withdrawn Heparin Versus no Heparin on Duration of Peripherally Inserted Central Catheter (PICC) Patency in Neonates
Conditions: Infant, Premature;   Anticoagulants;   Thrombosis
Interventions: Drug: heparin;   Drug: No heparin
20 Active, not recruiting Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children
Condition: Catheter-Related Infections
Interventions: Drug: Taurolidine;   Drug: Heparin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.